HK1171013A1 - 活性的抑制劑 - Google Patents

活性的抑制劑

Info

Publication number
HK1171013A1
HK1171013A1 HK12111698.8A HK12111698A HK1171013A1 HK 1171013 A1 HK1171013 A1 HK 1171013A1 HK 12111698 A HK12111698 A HK 12111698A HK 1171013 A1 HK1171013 A1 HK 1171013A1
Authority
HK
Hong Kong
Prior art keywords
akt
inhibitors
activity
akt activity
activity akt
Prior art date
Application number
HK12111698.8A
Other languages
English (en)
Inventor
Lixin Zhang
Graham Peter Trevitt
Hughes Miel
Frank Burkamp
Timothy Harrison
Andrew John Wilkinson
Charles-Henry Fabritius
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Publication of HK1171013A1 publication Critical patent/HK1171013A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK12111698.8A 2009-12-23 2012-11-16 活性的抑制劑 HK1171013A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0922589.7A GB0922589D0 (en) 2009-12-23 2009-12-23 Pharmaceutical compounds
PCT/GB2010/002329 WO2011077098A1 (en) 2009-12-23 2010-12-23 Inhibitors of akt activity

Publications (1)

Publication Number Publication Date
HK1171013A1 true HK1171013A1 (zh) 2013-03-15

Family

ID=41716932

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111698.8A HK1171013A1 (zh) 2009-12-23 2012-11-16 活性的抑制劑

Country Status (22)

Country Link
US (1) US9221838B2 (zh)
EP (1) EP2516435B8 (zh)
JP (1) JP5923043B2 (zh)
KR (1) KR20140015157A (zh)
CN (1) CN102791708B (zh)
AU (1) AU2010334591C1 (zh)
BR (1) BR112012015677A2 (zh)
CA (1) CA2783340C (zh)
CY (1) CY1115686T1 (zh)
DK (1) DK2516435T3 (zh)
ES (1) ES2503794T3 (zh)
GB (1) GB0922589D0 (zh)
HK (1) HK1171013A1 (zh)
IL (1) IL220153A (zh)
MX (1) MX2012007274A (zh)
NZ (1) NZ600453A (zh)
PL (1) PL2516435T3 (zh)
PT (1) PT2516435E (zh)
RU (1) RU2579513C2 (zh)
SG (1) SG181517A1 (zh)
SI (1) SI2516435T1 (zh)
WO (1) WO2011077098A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201205164D0 (en) 2012-03-23 2012-05-09 Almac Discovery Ltd Pharmaceutical compounds
AU2015370911B2 (en) * 2014-12-23 2020-07-09 Bergenbio Asa Inhibitors of Akt kinase
US10323044B2 (en) * 2015-02-27 2019-06-18 Taiho Pharmaceutical Co., Ltd. Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal
GB201603779D0 (en) 2016-03-04 2016-04-20 Mission Therapeutics Ltd Novel compounds
WO2018031407A1 (en) * 2016-08-07 2018-02-15 The Wistar Institute Of Anatomy And Biology Methods of detecting and treating a tumor expressing pt346 pdk1
CN111132972A (zh) * 2017-06-22 2020-05-08 克拉德夫制药有限公司 人sting的小分子调节剂
IL305085A (en) 2017-09-07 2023-10-01 Univ Res Inst Inc Augusta A specific AKT3 activator and its uses
GB2600384A (en) 2020-09-30 2022-05-04 Vaderis Therapeutics Ag Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0790997T3 (da) * 1994-11-14 2000-08-21 Warner Lambert Co 6-Aryl-pyrido[2,3-d]pyrimidiner og napthyridiner til hæmning af protein-tyrosin-kinase-fremkaldt celleproliferation
TWI301760B (en) * 2004-02-27 2008-10-11 Merz Pharma Gmbh & Co Kgaa Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
AU2005316826A1 (en) 2004-12-15 2006-06-22 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
PT1898903E (pt) * 2005-06-10 2013-06-28 Merck Sharp & Dohme Inibidores da atividade de akt
CA2656507C (en) * 2006-07-17 2012-03-20 Amgen Inc. Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
CA2670767A1 (en) 2006-12-06 2008-06-12 Merck & Co., Inc. Inhibitors of akt activity
AR064010A1 (es) 2006-12-06 2009-03-04 Merck & Co Inc Inhibidores de la actividad de la akt
US7999107B2 (en) * 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
MX2010013224A (es) 2008-06-03 2010-12-21 Merck Sharp & Dohme Inhibidores de la actividad de la serina/treonina cinasa.
CA2726317A1 (en) * 2008-06-03 2009-12-10 Merck Sharp & Dohme Corp. Inhibitors of akt activity

Also Published As

Publication number Publication date
GB0922589D0 (en) 2010-02-10
CA2783340C (en) 2015-11-24
SI2516435T1 (sl) 2014-12-31
US9221838B2 (en) 2015-12-29
CY1115686T1 (el) 2017-01-25
CN102791708B (zh) 2016-03-02
BR112012015677A2 (pt) 2015-06-30
WO2011077098A1 (en) 2011-06-30
SG181517A1 (en) 2012-07-30
AU2010334591C1 (en) 2014-07-31
EP2516435A1 (en) 2012-10-31
NZ600453A (en) 2013-10-25
AU2010334591A1 (en) 2012-06-21
RU2579513C2 (ru) 2016-04-10
MX2012007274A (es) 2012-10-03
KR20140015157A (ko) 2014-02-06
DK2516435T3 (da) 2014-10-13
CN102791708A (zh) 2012-11-21
WO2011077098A9 (en) 2012-04-19
IL220153A0 (en) 2012-07-31
IL220153A (en) 2015-05-31
EP2516435B8 (en) 2014-10-15
ES2503794T3 (es) 2014-10-07
JP2013515710A (ja) 2013-05-09
PL2516435T3 (pl) 2015-01-30
JP5923043B2 (ja) 2016-05-24
PT2516435E (pt) 2014-11-13
RU2012131115A (ru) 2014-01-27
CA2783340A1 (en) 2011-06-30
AU2010334591B2 (en) 2014-04-10
US20130116243A1 (en) 2013-05-09
EP2516435B1 (en) 2014-08-06

Similar Documents

Publication Publication Date Title
EP2391623A4 (en) INHIBITORS OF AKT ACTIVITY
EP2413932A4 (en) INHIBITORS OF AKT ACTIVITY
EP2303269A4 (en) HAMMER OF ACT ACTIVITY
EP2406250A4 (en) HAMMER OF ACT ACTIVITY
ZA201700326B (en) Inhibitors of beta-secretase
HK1132676A1 (zh) 活性的抑制劑
IL209488A0 (en) Inhibitors of akt activity
EP2114388A4 (en) INHIBITORS OF AKT'S ACTIVITY
HK1159102A1 (zh) 活性抑制劑
HK1137758A1 (en) Inhibitors of akt activity akt
HK1171390A1 (en) Heparanase activity inhibitor
EP2405756A4 (en) HAMMER OF ACT ACTIVITY
EP2303852A4 (en) ACTIVITY INHIBITORS AKT
EP2306825A4 (en) HAMMER OF ACT ACTIVITY
HK1171013A1 (zh) 活性的抑制劑
EP2134175A4 (en) HAMMER OF ACT ACTIVITY
ZA201206456B (en) Uses of dgati inhibitors
HK1171624A1 (zh) 認知能力下降的抑制劑
HK1167323A1 (zh) 認知能力下降抑制劑
EP2120951A4 (en) INHIBITORS OF AKT ACTIVITY
EP2579872A4 (en) HAMMER OF ACT ACTIVITY
EP2303277A4 (en) HAMMER OF ACT ACTIVITY
EP2303017A4 (en) HAMMER OF ACT ACTIVITY
EP2303258A4 (en) ACTIVITY INHIBITORS AKT
EP2513059A4 (en) HAMMER OF ACT ACTIVITY

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171223